Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-17

Clinical Trial Update: Treatment of Schizophrenic Patients With Ziprasidone

View source ↗

Summary

Completed clinical trial evaluating ziprasidone for schizophrenia with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Status: COMPLETED | Results posted: 2010-05-17